Piedmont Cancer Institute and Willowglade Technologies Announce Strategic Partnership to Deliver Personalized Patient Experience Platform

By implementing these advanced patient experience tools, we can maximize our operational efficiency across all seven of our clinics.”

— John Goodman, Chief Operating Officer at PCI

LAS VEGAS, NV, UNITED STATES, October 29, 2026 /EINPresswire.com/ — Piedmont Cancer Institute (PCI), a leading independent, physician-led community oncology practice, today announced a strategic partnership with Willowglade Technologies, a leader in patient involvement information technology. Through this collaboration, PCI will implement key components of Willowglade’s industry-leading Personalized Patient Experience platform across all seven of its Atlanta-area locations.

The integration of Willowglade’s platform represents a significant step forward in PCI’s ongoing mission to deliver comprehensive, world-class cancer care. By consolidating patient touchpoints into a unified digital ecosystem, the partnership will streamline operations, remove traditional administrative barriers, and empower patients with unprecedented access to their care teams.

“At Piedmont Cancer Institute, our mission since 1987 has been to care for the whole patient, addressing not only the clinical aspects of treatment but also supporting the mind, body, and spirit,” said John Goodman, Chief Operating Officer at PCI. “Partnering with Willowglade Technologies allows us to extend that compassionate care into the digital realm. By implementing these advanced patient experience tools, we can maximize our operational efficiency across all seven of our clinics, ease administrative burdens for our dedicated staff, and—most importantly—reduce patient anxiety by making their treatment journeys clearer and more predictable.”

“We are incredibly proud to partner with Piedmont Cancer Institute, an organization widely recognized for its clinical excellence and deep-rooted commitment to community oncology,” said John Papandrea, Chief Executive Officer at Willowglade Technologies. “Cancer care is uniquely complex, requiring close collaboration between patients and their care providers. Our platform is built on the philosophy that the patient is at the center of everything we do. By launching our Personalized Patient Experience components at PCI, we aim to establish a foundation for a seamless, connected digital environment that improves provider communication, drives patient engagement, and ultimately supports superior health outcomes.”

By integrating components of Willowglade’s platform, PCI will completely modernize its patient engagement capabilities. PCI anticipates substantial clinical, administrative, and experiential benefits across four major areas:

Itinerary Notifications: Cancer treatment often requires patients to navigate a labyrinth of same-day appointments. Willowglade’s automated itinerary notifications integrate directly with PCI’s scheduling system to send patients a single, consolidated message via text, email, or voice. Instead of multiple confusing reminders, patients receive one comprehensive itinerary outlining their day’s times, locations, and details.

Electronic Forms (Smart E-Forms): Willowglade’s Smart E-Forms enables patients to safely complete registration, insurance card uploads, and medical histories from the comfort of home. For patients who arrive without completing their paperwork, the clinic can instantly push a secure SMS link to their smartphone, allowing them to fill out forms digitally in the waiting room – eliminating physical paperwork, reduces manual data entry errors for staff, and dramatically cuts down on clinic wait times.

ePROs (Electronic Patient-Reported Outcomes): Monitoring a patient’s physical and emotional status between office visits is vital to successful oncology care. ePRO’s empowers patients to report symptoms, side effects, and quality-of-life indicators — from home. These structured patient insights can be delivered seamlessly into PCI’s Electronic Medical Record (EMR) as both discrete data and formatted PDFs, ensuring doctors have real-time visibility during consultations.

Streamlined Patient Arrival Process: PCI is fundamentally transforming its front-desk operations. The streamlined arrival process removes the friction of checking in, minimizing lobby crowding and bottlenecked registration lines. Patients spend less time sitting in waiting areas and more time receiving high-quality, focused care.

About Piedmont Cancer Institute

Founded in 1987, Piedmont Cancer Institute (PCI) is an independent, physician-led community oncology and hematology practice dedicated to providing exceptional, comprehensive cancer care throughout the greater Atlanta area. Owned and operated by exceptionally qualified physicians trained at the nation’s leading cancer programs, PCI operates seven state-of-the-art locations. PCI combines innovative clinical trials and advanced therapies with a steadfast commitment to supporting each patient’s emotional, physical, and overall well-being. For more information, visit www.piedmontcancerinstitute.com.


About Willowglade Technologies

Willowglade Technologies is a mission-driven healthcare information technology company dedicated to advancing the digital transformation of patient care. Its Unified Digital Patient Experience Platform empowers modern healthcare organizations, community practices, and clinical researchers to streamline patient communication, automate care coordination, and deliver highly personalized, data-driven support. By putting the patient at the center of every digital interaction, Willowglade helps providers improve operational workflows, elevate patient engagement, and drive improvements in clinical

Mike Lachapelle
Willowglade Technologies
mike.lachapelle@willowgladetechnologies.com

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery

About The Author